# Anterix Inc.: Form 10-Q/A for the period ended Sep 30, 2021

- Company: [Anterix Inc.](/companies/atex.md) (CIK 1304492)
- Form: 10-Q/A
- Filed: 2022-02-03
- Accepted by EDGAR: Feb 3, 2022, 16:22 ET
- Period: 2021-09-30
- Accession: 0001304492-22-000007
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1304492/000130449222000007/atex-20210930x10qa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1304492/000130449222000007/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-07-01 to 2021-09-30 | $182.0k | us-gaap:Revenues |
| Revenue | 6 months, 2021-04-01 to 2021-09-30 | $364.0k | us-gaap:Revenues |
| Research and development | 3 months, 2021-07-01 to 2021-09-30 | $930.0k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2021-04-01 to 2021-09-30 | $1.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2021-07-01 to 2021-09-30 | −$1.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2021-04-01 to 2021-09-30 | −$13.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2021-07-01 to 2021-09-30 | $152.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2021-04-01 to 2021-09-30 | $298.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-07-01 to 2021-09-30 | −$1.8m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2021-04-01 to 2021-09-30 | −$13.7m | us-gaap:NetIncomeLoss |
| Operating cash flow | 6 months, 2021-04-01 to 2021-09-30 | −$12.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2021-04-01 to 2021-09-30 | $209.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2021-09-30 | $100.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-09-30 | $106.4m | us-gaap:AssetsCurrent |
| Total assets | at 2021-09-30 | $256.7m | us-gaap:Assets |
| Current liabilities | at 2021-09-30 | $7.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-09-30 | $43.4m | us-gaap:Liabilities |
| Shareholders' equity | at 2021-09-30 | $213.3m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1304492/000130449222000007/atex-20210930x10qa.htm

Filed Feb 3, 2022.
Source: SEC EDGAR, the filing index for accession 0001304492-22-000007. Last ingested by Listed: Nov 11, 2026, 00:28 ET. No prices; not investment advice.
